- Home
- ARQT vs VSCO Comparison
ARQT vs VSCO Comparison
Compare ARQT & VSCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- VSCO
- Stock Information
- Founded
- ARQT 2016
- VSCO 1977
- Country
- ARQT United States
- VSCO United States
- Employees
- ARQT N/A
- VSCO N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- VSCO Clothing/Shoe/Accessory Stores
- Sector
- ARQT Health Care
- VSCO Consumer Discretionary
- Exchange
- ARQT Nasdaq
- VSCO Nasdaq
- Market Cap
- ARQT 1.7B
- VSCO 1.9B
- IPO Year
- ARQT 2020
- VSCO N/A
- Fundamental
- Price
- ARQT $13.82
- VSCO $18.84
- Analyst Decision
- ARQT Strong Buy
- VSCO Hold
- Analyst Count
- ARQT 6
- VSCO 12
- Target Price
- ARQT $18.80
- VSCO $26.50
- AVG Volume (30 Days)
- ARQT 1.9M
- VSCO 4.0M
- Earning Date
- ARQT 08-13-2025
- VSCO 06-11-2025
- Dividend Yield
- ARQT N/A
- VSCO N/A
- EPS Growth
- ARQT N/A
- VSCO 55.42
- EPS
- ARQT N/A
- VSCO 2.07
- Revenue
- ARQT $212,819,000.00
- VSCO $6,224,000,000.00
- Revenue This Year
- ARQT $61.15
- VSCO $2.23
- Revenue Next Year
- ARQT $37.98
- VSCO $1.77
- P/E Ratio
- ARQT N/A
- VSCO $9.07
- Revenue Growth
- ARQT 100.03
- VSCO 1.47
- 52 Week Low
- ARQT $7.86
- VSCO $13.76
- 52 Week High
- ARQT $17.75
- VSCO $48.73
- Technical
- Relative Strength Index (RSI)
- ARQT 50.73
- VSCO 41.35
- Support Level
- ARQT $12.97
- VSCO $18.25
- Resistance Level
- ARQT $13.84
- VSCO $23.33
- Average True Range (ATR)
- ARQT 0.61
- VSCO 1.02
- MACD
- ARQT 0.02
- VSCO -0.40
- Stochastic Oscillator
- ARQT 51.64
- VSCO 15.76
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About VSCO Victorias Secret & Co.
Victoria's Secret & Co is a retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. It also includes the merchandise sourcing and production function serving the Company and its international partners. The Company operates as a single segment designed to serve customers seamlessly through stores and online channels.